⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1053342 | 0.80 | — | — | |
| SCHEMBL23149820 | 0.51 | — | — | |
| SCHEMBL13834573 | 0.51 | — | — | |
| SCHEMBL23149826 | 0.46 | — | — | |
| SCHEMBL27750356 | 0.38 | — | — | |
| Methane SCHEMBL23044967 | 0.38 | — | — | |
| SCHEMBL3431209 | 0.38 | — | — | |
| SCHEMBL10484416 | 0.38 | — | — | |
| Hydrogen Sulfide SCHEMBL5316298 | 0.38 | — | — | |
| SCHEMBL23897360 | 0.27 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109745316-B | Combination therapy for the treatment of cancer | EPIZYME股份有限公司 | 2023-01-24 | — | — | CN | disclosed |
| US-20220204473-A1 | COMPOUND AS IRAK INHIBITOR | WUHAN CREATERNA SCIENCE AND TECHNOLOGY CO., LTD. (CN) | 2022-06-30 | — | — | US | disclosed |
| EP-3889150-A1 | COMPOUND SERVING AS IRAK INHIBITOR | Shanghai Meiyue Biotech Development Co., Ltd. (CN) | 2021-10-06 | — | — | EP | disclosed |
| CN-113227079-A | Compound as IRAK inhibitor | 上海美悦生物科技发展有限公司 | 2021-08-06 | — | — | CN | disclosed |
| CN-111448183-A | Novel compound, photopolymerization initiator containing the compound, and photosensitive resin composition containing the photopolymerization initiator | 日本化药株式会社 | 2020-07-24 | — | — | CN | disclosed |
| CN-111362920-A | Compound as IRAK inhibitor | 上海美悦生物科技发展有限公司 | 2020-07-03 | — | — | CN | disclosed |
| WO-2020135513-A1 | COMPOUND SERVING AS IRAK INHIBITOR | 上海美悦生物科技发展有限公司 | 2020-07-02 | — | — | WO | disclosed |
| WO-2014118796-A1 | AN IN-SITU PROCESS FOR THE PREPARATION OF HIGHLY PURE MONTELUKAST SODIUM | MELODY HEALTHCARE PVT. LTD. (IN) | 2014-08-07 | — | — | WO | disclosed |